Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report

Beta-blockers are well-known for their wide range of therapeutic applications, particularly in patients with cardiac diseases. Physicians worldwide are aware of their potential side effects, including hypoglycemia, dizziness, slow heart rate, fatigue, and heart block. We report a case of erythroderm...

Descripción completa

Detalles Bibliográficos
Autores principales: Voloshyna, Diana, Ehsan Ullah, Saad, Jahan, Nusrat, Yadlapalli, Sai Sreya, Zahoor, Mohammad Munim, Shams, Yumna, Sathish, Meenakshi, Sandhu, Qudsia I, Saleem, Farhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621099/
https://www.ncbi.nlm.nih.gov/pubmed/36337823
http://dx.doi.org/10.7759/cureus.29809
_version_ 1784821465603899392
author Voloshyna, Diana
Ehsan Ullah, Saad
Jahan, Nusrat
Yadlapalli, Sai Sreya
Zahoor, Mohammad Munim
Shams, Yumna
Sathish, Meenakshi
Sandhu, Qudsia I
Saleem, Farhan
author_facet Voloshyna, Diana
Ehsan Ullah, Saad
Jahan, Nusrat
Yadlapalli, Sai Sreya
Zahoor, Mohammad Munim
Shams, Yumna
Sathish, Meenakshi
Sandhu, Qudsia I
Saleem, Farhan
author_sort Voloshyna, Diana
collection PubMed
description Beta-blockers are well-known for their wide range of therapeutic applications, particularly in patients with cardiac diseases. Physicians worldwide are aware of their potential side effects, including hypoglycemia, dizziness, slow heart rate, fatigue, and heart block. We report a case of erythrodermic psoriasis caused by beta-blockers in a 61-year-old woman with no prior history of the skin condition. The diagnosis was made based on the characteristic histopathological picture and a Naranjo score of 6. She was administered 15 mg of methotrexate weekly and received supportive care. She recovered completely within two months and exhibited no recurrence of symptoms.
format Online
Article
Text
id pubmed-9621099
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96210992022-11-04 Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report Voloshyna, Diana Ehsan Ullah, Saad Jahan, Nusrat Yadlapalli, Sai Sreya Zahoor, Mohammad Munim Shams, Yumna Sathish, Meenakshi Sandhu, Qudsia I Saleem, Farhan Cureus Dermatology Beta-blockers are well-known for their wide range of therapeutic applications, particularly in patients with cardiac diseases. Physicians worldwide are aware of their potential side effects, including hypoglycemia, dizziness, slow heart rate, fatigue, and heart block. We report a case of erythrodermic psoriasis caused by beta-blockers in a 61-year-old woman with no prior history of the skin condition. The diagnosis was made based on the characteristic histopathological picture and a Naranjo score of 6. She was administered 15 mg of methotrexate weekly and received supportive care. She recovered completely within two months and exhibited no recurrence of symptoms. Cureus 2022-10-01 /pmc/articles/PMC9621099/ /pubmed/36337823 http://dx.doi.org/10.7759/cureus.29809 Text en Copyright © 2022, Voloshyna et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Voloshyna, Diana
Ehsan Ullah, Saad
Jahan, Nusrat
Yadlapalli, Sai Sreya
Zahoor, Mohammad Munim
Shams, Yumna
Sathish, Meenakshi
Sandhu, Qudsia I
Saleem, Farhan
Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
title Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
title_full Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
title_fullStr Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
title_full_unstemmed Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
title_short Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
title_sort beta-blocker-induced erythrodermic psoriasis: a case report
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621099/
https://www.ncbi.nlm.nih.gov/pubmed/36337823
http://dx.doi.org/10.7759/cureus.29809
work_keys_str_mv AT voloshynadiana betablockerinducederythrodermicpsoriasisacasereport
AT ehsanullahsaad betablockerinducederythrodermicpsoriasisacasereport
AT jahannusrat betablockerinducederythrodermicpsoriasisacasereport
AT yadlapallisaisreya betablockerinducederythrodermicpsoriasisacasereport
AT zahoormohammadmunim betablockerinducederythrodermicpsoriasisacasereport
AT shamsyumna betablockerinducederythrodermicpsoriasisacasereport
AT sathishmeenakshi betablockerinducederythrodermicpsoriasisacasereport
AT sandhuqudsiai betablockerinducederythrodermicpsoriasisacasereport
AT saleemfarhan betablockerinducederythrodermicpsoriasisacasereport

Ejemplares similares